Latest Ratios: P/E Ratio -1.9x · EV/EBITDA 15.5x · ROE -48.4%. (1996–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $196M | $161M | $173M | $537M | $588M | $541M | $817M | $829M | $717M | $658M | $501M |
| Enterprise Value | $319M | $285M | $313M | $699M | $713M | $640M | $902M | $907M | $734M | $721M | $534M |
| P/E Ratio → | -1.87 | — | — | — | — | 164.50 | — | 13.77 | 13.32 | 14.56 | 6.46 |
| P/S Ratio | 0.23 | 0.19 | 0.19 | 0.55 | 0.65 | 0.70 | 1.26 | 0.99 | 0.83 | 0.80 | 0.72 |
| P/B Ratio | 1.07 | 0.90 | 0.71 | 1.87 | 2.09 | 1.83 | 2.75 | 2.86 | 2.53 | 2.69 | 2.61 |
| P/FCF | 16.08 | 13.22 | 7.38 | — | — | — | — | — | 13.85 | 14.07 | 12.27 |
| P/OCF | 5.75 | 4.73 | 3.62 | 108.58 | 86.35 | — | 28.52 | 33.82 | 8.87 | 8.34 | 7.67 |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 0.33 | 0.34 | 0.72 | 0.79 | 0.83 | 1.39 | 1.09 | 0.85 | 0.87 | 0.77 |
| EV / EBITDA | 15.47 | 13.78 | 9.05 | 15.03 | 18.90 | 12.83 | 35.28 | 8.82 | 7.63 | 8.45 | 7.93 |
| EV / EBIT | — | — | 368.53 | 61.51 | — | 36.30 | — | 12.47 | 10.52 | 12.35 | 11.75 |
| EV / FCF | — | 23.39 | 13.36 | — | — | — | — | — | 14.19 | 15.42 | 13.09 |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 19.0% | 19.0% | 20.8% | 20.7% | 19.4% | 21.7% | 23.8% | 25.6% | 29.6% | 30.1% | 28.1% |
| Operating Margin | -1.4% | -1.4% | -0.0% | 1.3% | 0.3% | 2.0% | -1.2% | 8.5% | 7.7% | 7.0% | 6.3% |
| Net Profit Margin | -11.9% | -11.9% | -1.8% | -0.5% | -1.6% | 0.4% | -1.2% | 7.2% | 6.2% | 5.5% | 11.1% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -48.4% | -48.4% | -6.2% | -1.8% | -4.9% | 1.1% | -2.7% | 21.0% | 20.4% | 20.7% | 51.9% |
| ROA | -17.5% | -17.5% | -2.5% | -0.8% | -2.1% | 0.5% | -1.3% | 10.4% | 9.6% | 9.5% | 20.4% |
| ROIC | -2.6% | -2.6% | -0.1% | 2.2% | 0.5% | 3.0% | -1.5% | 16.0% | 16.5% | 16.2% | 16.7% |
| ROCE | -2.7% | -2.7% | -0.1% | 2.6% | 0.6% | 3.2% | -1.6% | 16.3% | 16.0% | 16.3% | 16.4% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 1.06 | 1.06 | 0.86 | 0.71 | 0.64 | 0.62 | 0.54 | 0.51 | 0.35 | 0.53 | 0.44 |
| Debt / EBITDA | 9.20 | 9.20 | 6.13 | 4.36 | 4.77 | 3.69 | 6.22 | 1.43 | 1.02 | 1.51 | 1.24 |
| Net Debt / Equity | — | 0.69 | 0.57 | 0.56 | 0.45 | 0.33 | 0.29 | 0.27 | 0.06 | 0.26 | 0.17 |
| Net Debt / EBITDA | 5.99 | 5.99 | 4.05 | 3.49 | 3.32 | 1.98 | 3.33 | 0.76 | 0.18 | 0.74 | 0.49 |
| Debt / FCF | — | 10.16 | 5.98 | — | — | — | — | — | 0.34 | 1.35 | 0.82 |
| Interest Coverage | -3.08 | -3.08 | 0.06 | 0.87 | -0.51 | 3.40 | -0.75 | 16.82 | 14.78 | 10.09 | 7.24 |
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.30 | 2.30 | 2.58 | 2.41 | 2.30 | 2.37 | 2.29 | 2.39 | 2.17 | 2.23 | 2.14 |
| Quick Ratio | 1.45 | 1.45 | 1.57 | 1.36 | 1.45 | 1.58 | 1.67 | 1.72 | 1.64 | 1.69 | 1.60 |
| Cash Ratio | 0.42 | 0.42 | 0.48 | 0.23 | 0.31 | 0.49 | 0.51 | 0.50 | 0.55 | 0.48 | 0.45 |
| Asset Turnover | — | 1.56 | 1.46 | 1.44 | 1.38 | 1.16 | 1.04 | 1.39 | 1.55 | 1.47 | 1.76 |
| Inventory Turnover | 5.26 | 5.26 | 4.75 | 4.12 | 4.75 | 4.37 | 5.45 | 6.64 | 7.69 | 7.84 | 8.33 |
| Days Sales Outstanding | — | 55.70 | 55.36 | 62.30 | 64.15 | 71.25 | 77.02 | 60.62 | 58.60 | 63.06 | 59.38 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — | — | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | — | 0.6% | — | 7.3% | 7.5% | 6.9% | 15.5% |
| FCF Yield | 6.2% | 7.6% | 13.5% | — | — | — | — | — | 7.2% | 7.1% | 8.1% |
| Buyback Yield | 0.2% | 0.2% | 0.5% | 0.3% | 0.1% | 0.5% | 0.8% | 6.5% | 0.6% | 0.4% | 0.3% |
| Total Shareholder Yield | 0.2% | 0.2% | 0.5% | 0.3% | 0.1% | 0.5% | 0.8% | 6.5% | 0.6% | 0.4% | 0.3% |
| Shares Outstanding | — | $28M | $28M | $27M | $27M | $27M | $27M | $28M | $29M | $29M | $28M |
Persistent negative operating margins
According to recent market data, Stoneridge trades at a negative trailing P/E of -1.98, while its forward P/E of 28.23 suggests that investors are pricing in a significant recovery that remains unsupported by the company's current inability to generate consistent positive net income or cash flow.
The valuation appears disconnected from the company's fundamental reality, as the market seems to be assigning a premium based on the potential of the MirrorEye platform rather than current earnings. This forward-looking multiple warrants caution, as it implies a rapid return to profitability that may be delayed by the cyclical nature of the commercial vehicle market.
As reported in financial statements, Stoneridge's ROIC has deteriorated into negative territory, reaching -2.4% in 2026Q1, which indicates that the company is currently destroying shareholder value rather than compounding it through its investments in new vision-based technologies and manufacturing infrastructure.
The consistent decline in return on invested capital suggests that the firm's R&D and capital expenditures are not yet yielding the expected margin expansion. Investors should monitor whether this trend is a temporary byproduct of the product transition or a structural issue with the company's ability to achieve scale in its high-tech segments.
Based on the provided quarterly data, Stoneridge's cash conversion cycle has lengthened to 97 days in 2026Q1, reflecting a deterioration in working capital efficiency that suggests the company is facing increased difficulty in managing its inventory levels and collecting receivables from its OEM customer base.
The rising CCC indicates that capital is becoming increasingly trapped in operations, which exacerbates the company's liquidity constraints during this period of negative cash flow. The inability to optimize the cash conversion cycle may force the company to rely on external financing if the current operational environment does not improve.
According to the latest balance sheet filings, Stoneridge's debt-to-equity ratio has climbed to 1.04, a notable increase from historical levels that highlights the company's growing reliance on debt to fund operations as its equity base is eroded by persistent net losses.
While the debt levels are not yet at critical thresholds, the trend of rising leverage in the context of negative operating margins is concerning. The lack of positive interest coverage suggests that the company's ability to service its debt obligations may become increasingly strained if the current cyclical downturn persists.
The P/S ratio is the most commonly misapplied metric for Stoneridge, as it obscures the company's underlying profitability issues and high fixed-cost structure, which make revenue growth a poor proxy for value creation in a business currently struggling to achieve positive operating margins.
Investors should prioritize EV/EBITDA or FCF-based metrics over P/S, as these better reflect the company's ability to convert sales into actual cash flow. Relying on revenue multiples may lead to an overestimation of the company's health by ignoring the significant costs required to maintain its competitive position in the vision systems market.
Includes 30+ ratios · 30 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying SRI stock.
Stoneridge, Inc.'s current P/E ratio is -1.9x. The historical average is 29.1x.
Stoneridge, Inc.'s current EV/EBITDA is 15.5x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 10.4x.
Stoneridge, Inc.'s return on equity (ROE) is -48.4%. The historical average is 2.6%.
Based on historical data, Stoneridge, Inc. is trading at a P/E of -1.9x. Compare with industry peers and growth rates for a complete picture.
Stoneridge, Inc. has 19.0% gross margin and -1.4% operating margin.
Stoneridge, Inc.'s Debt/EBITDA ratio is 9.2x, indicating high leverage. A ratio above 4x may signal elevated financial risk.